Augmenting Internet-Based Cognitive Behavioral Therapy for Major Depressive Disorder With Low-Level Light Therapy
Launched by UNIVERSITY OF TEXAS AT AUSTIN · Sep 7, 2016
Trial Information
Current as of August 02, 2025
Terminated
Keywords
ClinConnect Summary
1. Online screening Following a digital informed consent, all participants will complete a brief online screening questionnaire to determine the severity level of their depression, using the Center for Epidemiological Studies - Depression Scale (CES-D). Initial consent and screening procedures will be conducted online via Research Electronic Data Capture (REDCap), a secure, on-line assessment tool designed to collect self-report questionnaire data for research studies. Participants with a CES-D score of 16 or higher will be eligible to continue with the study. At this initial screening, eli...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • ability to speak, read, and understand English fluently
- • owns a smartphone and able to receive emails on their phone and access REDCap on a web browser on their phone
- • current depressive episode as determined by the Center for Epidemiological Studies - Depression Screening (CES-D) and Mini International Neuropsychiatric Interview (MINI)
- Exclusion Criteria:
- • serious medical complications, including conditions that change electrical functioning in the brain (e.g., cancer, diabetes, epilepsy, head trauma, history of brain surgery, neurocognitive impairment, stroke, transient ischemic attack)
- • comorbid psychiatric disorders, excluding anxiety disorders, as determined by Mini International Neuropsychiatric Interview (MINI)
About University Of Texas At Austin
The University of Texas at Austin, a leading research institution, is dedicated to advancing knowledge and innovation in the field of healthcare through rigorous clinical trials. Known for its commitment to scientific excellence, the university leverages its diverse expertise and cutting-edge facilities to conduct research that addresses critical health challenges. Collaborating with a multidisciplinary team of researchers, clinicians, and students, the University of Texas at Austin aims to translate scientific discoveries into effective treatments and interventions, ultimately enhancing patient outcomes and contributing to the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Austin, Texas, United States
Patients applied
Trial Officials
Christopher G Beevers, Ph.D.
Principal Investigator
Psychology Department, University of Texas at Austin
Francisco Gonzalez-Lima, Ph.D.
Principal Investigator
Psychology Department, University of Texas at Austin
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials